Cogent Biosciences Inc
NASDAQ:COGT 3:59:53 PM EDT
Earnings Announcements
Cogent Biosciences Reports Recent Business Highlights And First Quarter 2022 Financial Results
Published: 05/10/2022 11:43 GMT
Cogent Biosciences Inc (COGT) - Cogent Biosciences Reports Recent Business Highlights and First Quarter 2022 Financial Results.
Cogent Biosciences Inc - Ended 1q 2022 With $191.0 Million in Cash, Sufficient to Fund Operations Into 2024.
Cogent Biosciences Inc - Ended 1q 2022 With $191.0 Million in Cash, Sufficient to Fund Operations Into 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.65
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.62
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.65
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.62
More details on our Analysts Page.